On April 1, the Trump administration slashed the organization that supported that research — the Agency for Healthcare ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

In a survey last year by the American Medical Association, 93% of doctors said that insurers’ prior authorization practices ...

The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.

The FDA has approved Imfinzi (durvalumab) as neoadjuvant and adjuvant treatment in patients with muscle-invasive bladder cancer.

Some patients with locally advanced esophageal cancer may be able to safely forgo esophagectomy after CRT, data suggest.

More than 3.8 million US lung cancer deaths were averted during 1970-2022 due to tobacco control, researchers say.

Clinical guidelines should establish clear timelines, and health care systems should prioritize timely treatment initiation and completion,” researchers concluded.

Patients with metastatic NSCLC may benefit from continuing on pembrolizumab-based treatment after progressing on that treatment.

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.

Partial nephrectomy provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC), according to research presented at the 40th ...